SCHEMBL17248296

SCHEMBL17248296

c1ccc(-n2c3ccccc3c3c2ccc2c4ccccc4n(-c4cccc(-n5c6ccccc6c6ccc7c(c8ccccc8n7-c7ccccn7)c65)c4)c23)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 3/20 0.33
MAT2A P31153 2/20 0.33
DPP4 P27487 1/20 0.33
KHK P50053 1/20 0.33
GAA P10253 1/20 0.33
HTR7 P34969 1/20 0.33
POLB P06746 3/20 0.33
MEN1 O00255 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
NPC1 O15118 1/20 0.32
S1PR4 O95977 1/20 0.32
XBP1 P17861 1/20 0.32
S1PR1 P21453 1/20 0.32
CCR6 P51684 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16807373 0.95 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1MAT2A
SCHEMBL10027507 0.92 KDM4E (0.45) KDM4EATML3MBTL1ALDH1A1DPP4
SCHEMBL17248313 0.90 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1DPP4
SCHEMBL10027528 0.89 POLB (0.37) KDM4EATML3MBTL1ALDH1A1MAT2A
SCHEMBL15763795 0.88 KDM4E (0.40) KDM4EATML3MBTL1MAT2ADPP4
SCHEMBL17248206 0.87 KDM4E (0.41) KDM4EATML3MBTL1GAAMEN1
SCHEMBL16484942 0.87 KDM4E (0.45) KDM4EATML3MBTL1ALDH1A1MAT2A
SCHEMBL16484313 0.87 KDM4E (0.45) KDM4EATML3MBTL1ALDH1A1MAT2A
SCHEMBL10059693 0.87 KDM4E (0.49) KDM4EATML3MBTL1ALDH1A1DPP4
SCHEMBL16999744 0.86 KDM4E (0.43) KDM4EATML3MBTL1ALDH1A1MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 KDM4E 1228/4885ATM 3768/4885L3MBTL1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.